OSI PHARMACEUTICALS, INC. CONSULTING AND CONFIDENTIAL DISCLOSURE AGREEMENTConsulting and Confidential Disclosure Agreement • November 6th, 2009 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
This Consulting and Confidential Disclosure Agreement (“Agreement”) is effective as of October 1, 2009 (“Effective Date”) by and between OSI Pharmaceuticals, Inc., a Delaware corporation (together with its affiliates and subsidiaries, “OSI”), having executive offices at 41 Pinelawn Road, Melville, New York 11747, and H.M. (Bob) Pinedo, M.D., Ph.D., an individual (“Consultant”), having an address at Gladiolenweg 6, Willemstad, Curacao, Netherlands Antilles.
OSI PHARMACEUTICALS, INC. CONSULTING AND CONFIDENTIAL DISCLOSURE AGREEMENTConsulting and Confidential Disclosure Agreement • February 28th, 2008 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
This Consulting and Confidential Disclosure Agreement (“Agreement”) is effective as of the 23rd day of August, 2007 (“Effective Date”) by and between OSI Pharmaceuticals, Inc., a Delaware corporation (together with its subsidiaries, “OSI”), having executive offices at 41 Pinelawn Road, Melville, New York 11747, and Walter M. Lovenberg, Ph.D., an individual (“Consultant”).
OSI PHARMACEUTICALS, INC. CONSULTING AND CONFIDENTIAL DISCLOSURE AGREEMENTConsulting and Confidential Disclosure Agreement • August 7th, 2009 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
This Consulting and Confidential Disclosure Agreement (“Agreement”) is effective as of the date of the last party to sign below (“Effective Date”) by and between OSI Pharmaceuticals, Inc., a Delaware corporation (together with its subsidiaries, “OSI”), having executive offices at 41 Pinelawn Road, Melville, New York 11747, and Daryl Granner, M.D., an individual (“Consultant”).
